News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
25,770 Results
Type
Article (1381)
Company Profile (2)
Press Release (24387)
Section
Business (12709)
Career Advice (15)
Deals (1817)
Drug Delivery (18)
Drug Development (2957)
Employer Resources (1)
FDA (460)
Job Trends (651)
News (17318)
Policy (949)
Tag
Academia (37)
Allergies (1)
Alliances (1250)
Alzheimer's disease (20)
Antibody-drug conjugate (ADC) (2)
Approvals (462)
Artificial intelligence (5)
Bankruptcy (3)
Best Places to Work (527)
BIOSECURE Act (1)
Biosimilars (3)
Biotechnology (1)
Bladder cancer (2)
Brain cancer (1)
Breast cancer (4)
Cancer (58)
Cardiovascular disease (8)
Career advice (14)
CAR-T (2)
Cell therapy (9)
Clinical research (2584)
Collaboration (16)
Compensation (9)
COVID-19 (34)
CRISPR (1)
C-suite (1)
Data (87)
Depression (4)
Diabetes (17)
Diagnostics (168)
Digital health (1)
Drug discovery (5)
Drug pricing (2)
Drug shortages (8)
Duchenne muscular dystrophy (2)
Earnings (10555)
Editorial (6)
Employer resources (1)
Events (1838)
Executive appointments (6)
FDA (521)
Funding (11)
Gene editing (4)
Gene therapy (2)
GLP-1 (42)
Government (71)
Guidances (39)
Healthcare (568)
Huntington's disease (2)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (1)
Infectious disease (38)
Inflammatory bowel disease (2)
Intellectual property (3)
Interviews (1)
IPO (1220)
IRA (1)
Job creations (159)
Job search strategy (14)
Kidney cancer (2)
Labor market (1)
Layoffs (13)
Legal (190)
Liver cancer (1)
Lung cancer (7)
Lymphoma (8)
Manufacturing (33)
MASH (2)
Medical device (572)
Medtech (572)
Mergers & acquisitions (614)
Metabolic disorders (51)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (4)
Neuropsychiatric disorders (1)
Neuroscience (34)
NextGen: Class of 2025 (154)
Non-profit (51)
Obesity (37)
Opinion (3)
Ovarian cancer (1)
Pain (2)
Pancreatic cancer (1)
Partnered (1)
Patents (2)
Patient recruitment (4)
Peanut (1)
People (1141)
Pharmacy benefit managers (1)
Phase I (681)
Phase II (1087)
Phase III (974)
Pipeline (181)
Policy (3)
Postmarket research (92)
Preclinical (224)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (5)
Rare diseases (10)
Real estate (178)
Recruiting (1)
Regulatory (734)
Reports (2)
Research institute (20)
Resumes & cover letters (1)
RSV (3)
Schizophrenia (2)
Series A (3)
Special edition (1)
Spinal muscular atrophy (13)
Startups (121)
Supply chain (9)
Tariffs (1)
The Weekly (2)
Vaccines (16)
Venture capitalists (2)
Weight loss (33)
Date
Last 7 days (72)
Last 30 days (138)
Last 365 days (1355)
2025 (494)
2024 (1573)
2023 (1658)
2022 (1791)
2021 (1912)
2020 (1715)
2019 (1326)
2018 (1010)
2017 (1984)
2016 (4485)
2015 (638)
2014 (421)
2013 (262)
2012 (349)
2011 (357)
2010 (419)
Location
Africa (22)
Alabama (1)
Arizona (2)
Asia (1358)
Australia (183)
California (279)
Canada (64)
China (25)
Colorado (25)
Connecticut (19)
Delaware (6)
Europe (3318)
Florida (59)
Georgia (10)
Idaho (1)
Illinois (21)
India (1)
Indiana (25)
Japan (5)
Kansas (3)
Louisiana (1)
Maine (1)
Maryland (36)
Massachusetts (181)
Michigan (7)
Minnesota (20)
Missouri (2)
Nevada (2)
New Hampshire (6)
New Jersey (63)
New York (61)
North Carolina (33)
Northern California (160)
Ohio (11)
Pennsylvania (57)
South America (34)
Southern California (85)
Tennessee (1)
Texas (20)
United States (974)
Utah (14)
Virginia (5)
Washington D.C. (2)
Washington State (26)
25,770 Results for "165".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Catalent Misses Fiscal Q1 Revenue Expectations as Pressure Mounts on Novo Holdings’ $16.5B Buyout
The contract manufacturer fell short of Wall Street’s projections for its first quarter of fiscal 2025, which ended Sept. 30, 2024. The miss comes amid growing opposition to Novo Holdings’ proposed $16.5 billion acquisition of Catalent.
November 6, 2024
·
3 min read
·
Tristan Manalac
Press Releases
Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support
March 18, 2025
·
3 min read
Press Releases
Caidya Announces $165 Million Strategic Growth Investment From Rubicon Founders
January 13, 2025
·
3 min read
Press Releases
Sound Blade Medical Closes $16.5 Million Series A Financing to Advance the Development of Innovative Handheld Histotripsy Therapy
January 30, 2025
·
2 min read
Mergers & acquisitions
Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Acquisition
Now that they’ve received the go-signal from both U.S. and EU anti-trust regulators, Novo Holdings and Catalent expect to wrap up their deal in the coming days.
December 16, 2024
·
2 min read
·
Tristan Manalac
Deals
Novo’s $16.5B Deal with Catalent Gets Another 30 Days Added to FTC Antitrust Review
The Federal Trade Commission has asked for an additional 30 days for its review of Novo Nordisk’s $16.5 billion acquisition of Catalent, with the companies expecting to complete the merger by the end of 2024.
May 6, 2024
·
2 min read
·
Tristan Manalac
Obesity
Rhythm Drug Leads to Reduced BMI in Rare Obesity Indication
Stifel analysts were bullish on the data, which showed a 16.5% drop in body-mass index among patients with damage to the hypothalamus taking Rhythm Pharmaceuticals’ Imcivree.
April 7, 2025
·
2 min read
·
Dan Samorodnitsky
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
In the U.S., the chorus of opposition against the proposed buyout continues to grow and now includes the CEOs of Roche and Lilly, a broad coalition of unions and consumer groups and at least one senator.
December 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Gene Synthesis Service Market Size Skyrockets by 16.5% CAGR to Hit $3138.64 Mn by 2034
December 10, 2024
·
1 min read
Press Releases
Nicox and Soleus Sign $16.5 million Royalty and Equity Financing
October 14, 2024
·
18 min read
1 of 2,577
Next
